Manufacturer record
Recipharm Pharmaservices Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Recipharm Pharmaservices Pvt. Ltd (Karnataka) were declared Not of Standard Quality between August 2019 and August 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
1 record linked to Recipharm Pharmaservices Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Dulcoflex (Biscodyl Tablets I.P. 5 mg) | DLA18146Mfg 2018-12 · Exp 2021-11 | DisintegrationDisintegration | CDL KolkataCDSCO lab | Aug 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.